Having trouble accessing articles? Reset your cache.
Acetylon Pharmaceuticals Inc. (Boston, Mass.) said Celgene Corp. (NASDAQ:CELG) will acquire it for undisclosed terms. Prior to the deal's completion, Acetylon will spin out
Get a two-week free trial subscription to BioCentury